🔗 Share this article

Treasury head Rachel Reeves has stated she is planning "focused measures to tackle household expense issues" in the forthcoming financial statement.

During an interview with the BBC, she emphasized that lowering price rises is a joint task of both the administration and the Bank of England.

The United Kingdom's price growth is forecast to be the highest among the Group of Seven developed nations this year and the following year.

Potential Utility Cost Interventions

Reports indicate the government could take action to bring down utility costs, for example by reducing the present 5% rate of value-added tax applied on energy.

A further approach is to cut some of the regulatory levies presently included in bills.

Budgetary Limitations and Analyst Expectations

The government will receive the latest report from the official forecaster, the Office for Budget Responsibility, on Monday, which will show how much scope there is for these actions.

The view from the majority of analysts is that the Chancellor will have to declare tax increases or expenditure reductions in order to fulfill her declared borrowing rules.

Earlier on the same day, estimates indicated there was a £22 billion gap for the chancellor to fill, which is at the lower end of projections.

"It is a shared task between the Bank of England and the administration to bear down further on some of the sources of inflation," Reeves informed the BBC in the US capital, at the conferences of the International Monetary Fund and global financial institution.

Revenue Pledges and International Concerns

While a great deal of the attention has been on likely tax rises, the chancellor said the most recent information from the OBR had not changed her commitment to campaign commitments not to raise rates on earnings tax, sales tax or social security contributions.

She attributed an "uncertain world" with rising international and commercial tensions for the Budget revenue measures, likely to be directed on those "most able to pay."

Global Trade Disputes

Addressing worries about the United Kingdom's trade ties with China she said: "Our security interests always come first."

Last week's declaration by China to strengthen trade restrictions on rare earths and other materials that are crucial for high-technology manufacturing led American leader the US President to threaten an additional 100% tariff on goods from the Asian country, raising the possibility of an full-scale commercial conflict between the two largest economies.

The US Treasury Secretary described China's decision "economic coercion" and "a global supply chain power grab."

Questioned on accepting the US offer to participate in its conflict with the Asian nation, Reeves said she was "extremely troubled" by Chinese actions and urged the Chinese government "to avoid restrictions and restrict access."

She said the decision was "damaging for the world economy and generates further obstacles."

"In my view there are fields where we must confront China, but there are also significant prospects to export to China's economy, including banking sector and other areas of the economy. We've got to achieve that equilibrium right."

The Treasury chief also affirmed she was cooperating with international partners "on our own essential resources plan, so that we are less reliant."

Health Service Drug Costs and Investment

The Chancellor also recognized that the price the National Health Service pays for pharmaceuticals could increase as a consequence of ongoing talks with the Trump administration and its drugs companies, in exchange for lower tariffs and investment.

Some of the biggest global drug companies have said recently that they are either pausing or scrapping investments in the UK, with some blaming the modest returns they are getting.

Recently, the Science Minister said the cost the NHS spends on drugs would have to rise to halt businesses and pharmaceutical investment leaving the United Kingdom.

Reeves stated to the BBC: "It has been observed because of the pricing regime, that drug testing, new drugs have not been available in the United Kingdom in the manner that they are in other continental states."

"We want to ensure that patients getting treatment from the NHS are able to receive the top life-saving treatments in the world. And so we are reviewing this situation, and... aiming to attract increased capital into Britain."